Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR® Read more about Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR®
Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR® Read more about Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR®
Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings Read more about Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings
Supernus to Present at the 2017 J.P. Morgan Healthcare Conference Read more about Supernus to Present at the 2017 J.P. Morgan Healthcare Conference
Supernus Receives Nasdaq Non-Compliance Notice Read more about Supernus Receives Nasdaq Non-Compliance Notice
Supernus to Present at Three November Healthcare Conferences Read more about Supernus to Present at Three November Healthcare Conferences
Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD Read more about Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD